Cite

    Hu, F. et al. (2022). Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment‐mediated protein nanocages for enhancing cancer biotherapy. Bioengineering & translational medicine. 7 (2), p. n/a. [Online].